News Sentiment

DYN sentiment intelligence

Dyne Therapeutics Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 51 Balanced news tone 56 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 23.42 Week of 10 Jul 2026
Weighted tone 51/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

85/100 classification confidence.

Company focus 48

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend active

+1.5% over one week, +28.8% over four weeks, trend active, and near fair-value range.

Latest direct headline Neutral

Dyne Therapeutics (DYN) Inspires Confidence With Its Force Platform

Market Reaction

Balanced read

61/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 85/100 classification
One-week reaction 1.5% Price digesting
Trend fit Trend active 28.8% over four weeks
Fair value 19.4% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 14
Neutral 34
Negative 8

Relevance

Why the article matched

Direct first
Direct company coverage 48
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Market source 9
Stock Titan 8
TradingView 6
simplywall.st 5
Investing.com 4
Investing.com Canada 3
MT Newswires 3
GlobeNewswire 3

Event Lens

What the news is about

Classified themes
Market update 39
Earnings 11
Analyst action 3
Deals and strategy 1
Regulatory and legal 1
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-56 of 56
TradingView Direct company coverage

Dyne Therapeutics Inc Actuals & Estimates (NASDAQ:DYN)

This article provides an overview of Dyne Therapeutics Inc. (NASDAQ: DYN), including its current stock price, historical performance, analyst forecasts, and financial data. It highlights the company's market capitalization, upcoming earnings report, and recent earnings and revenu

Tone
Positive 72/100
Event
Earnings
Published
26 Jun 2026 01:40
Source
TradingView
Investing.com Canada Direct company coverage

Form 4 Dyne Therapeutics Inc For: 24 June By Investing.com

This article from Investing.com reports on a Form 4 filing for Dyne Therapeutics Inc. dated June 24. It provides no further details on the filing but includes stock market performance data for Dyne Therapeutics (DYN) and various indices and commodities. The article appears to be

Tone
Neutral 50/100
Event
Market update
Published
25 Jun 2026 23:39
Source
Investing.com Canada